NCT06169384

Brief Summary

Efficacy of partial adenoidectomy versus total adenoidectomy regarding rate of recurrence and relief of nasal obstruction.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 28, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

December 13, 2023

Status Verified

December 1, 2023

Enrollment Period

1.5 years

First QC Date

November 28, 2023

Last Update Submit

December 5, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Efficacy of partial adenoidectomy versus total adenoidectomy regarding rate of recurrence and relief of nasal obstruction.

    1\. Relief of nasal obstruction while preserving the function of velopharyngeal valve and assessment of the recurrence rate.

    1 to 2 years .

  • Incidence of recurrence using fibro-optic evaluation

    Relief of nasal obstruction of posterior nasal chona using fibro-optic evaluation and assessment of recurrence rate using also questionnaires sheets to all parents.

    1 to 2 years .

Study Arms (2)

Endoscopic total adenoidectomy

ACTIVE COMPARATOR
Device: Endoscopic adenoidectomy

Endoscopic partial adenoidectomy

ACTIVE COMPARATOR
Device: Endoscopic adenoidectomy

Interventions

Subjects will be randomly assigned into two groups (30 patient each group): Group A will undergo endoscopic partial adenoidectomy using the 70◦ rigid endoscope trans-orally and shaver (microdebrider) ,by removing the upper (choanal) part only with leaving the lower part of the adenoid .(2) Group B will undergo total adenoidectomy ,by removing all the adenoid lymphoid tissue .

Endoscopic partial adenoidectomyEndoscopic total adenoidectomy

Eligibility Criteria

Age1 Year+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • all patients with adenoid hypertrophy causing airway obstruction.

You may not qualify if:

  • \. Chlidren known to have cleft palate ,submucous cleft palate or other medical problems causing velopharyngeal insufficiency.
  • Systemic medical problems interfering with surgery.
  • Refusal of parents to participate.
  • \. Craniofacial abnormalities.
  • \. Down syndrome.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AssiutU

Asyut, 71515, Egypt

RECRUITING

Related Publications (3)

  • 1. Jervis-Bardy, J.; Department of Otolaryngology, Arkansas Children's Hospital, cLittle Rock, AR, United States. Journal of Craniofacial SurgeryVolume 30, Issue 5, Pages E454 - E4602019.

    BACKGROUND
  • 1. Kummer AW, Lee L. Evaluation and treatment of resonance disorders. Language, Speech, and Hearing Services in Schools, 27:271-281

    BACKGROUND
  • Saunders NC, Hartley BE, Sell D, Sommerlad B. Velopharyngeal insufficiency following adenoidectomy. Clin Otolaryngol Allied Sci. 2004 Dec;29(6):686-8. doi: 10.1111/j.1365-2273.2004.00870.x.

    PMID: 15533160BACKGROUND

Central Study Contacts

Mohamed M Roshdy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident investigator

Study Record Dates

First Submitted

November 28, 2023

First Posted

December 13, 2023

Study Start

September 1, 2022

Primary Completion

March 1, 2024

Study Completion

June 1, 2024

Last Updated

December 13, 2023

Record last verified: 2023-12

Locations